Suboxone Virginia Addiction Medicine

Suboxone Virginia Addiction Medicine

Suboxone is the first opioid medication approved under DATA 2000 for the treatment of opioid dependence in an office-based setting. Suboxone also can be dispensed for take-home use, just as any other medicine for other medical conditions.

The primary active ingredient in Suboxone is buprenorphine.

Suboxone Virginia Addiction Medicine

Because buprenorphine is a partial opioid agonists, its opioid effects are limited compared with those produced by full opioid agonists, such as oxycodone or heroin. Suboxone also contains naloxone, an opioid antagonist.

The naloxone in Suboxone is there to discourage people from dissolving the tablet and injecting it. When SUBOXONE is placed under the tongue, as directed, very little naloxone reaches the bloodstream, so what the patient feels are the effects of the buprenorphine. However, if naloxone is injected, it can cause that person to quickly go into withdrawal.

Suboxone at the appropriate dose may be used to:

  • Suppress symptoms of opioid withdrawal
  • Decrease cravings for opioids
  • Reduce illicit opioid use
  • Block the effects of other opioids
  • Help patients stay in treatment

Other medications now available are Zubsolv and Bunavail, all have the same active ingredient, buprenorphine, also oral medications with a different formulary and delivery system. All drugs in this class are highly effective in the treatment of opioid dependency!


ALL Services Temporarily Provided via Telehealth ONLY

Due to the rise in COVID infections, we have temporarily closed our offices for on site visits, however, ALL services are provided virtually. For questions, please call our offices or email us through our contact page here and someone will get back as soon as possible.

We are monitoring the local COVID case count and will return to providing onsite services as soon as we believe it is safe to do so. An updated bulletin will be posted to our website and current patients will also be notified ahead of their scheduled appointment when we will return back to the offices for onsite visits. Thank you for your patience as we continue to navigate Covid Pandemic conditions.

Kindest regards,


Skip to content